C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.
By D. Freeman, J. Norrie, M. Caslake, A. Gaw, Ian Ford, G. Lowe, D. O'reilly, C. Packard, N. Sattar. Diabetes, 2002
776 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery
View Paper: https://www.semanticscholar.org/paper/c4910cc76f77eac7410a96fecdf13327f104d65b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- P. Ridker
- B. K. Pedersen
- N. Rifai
- J. Pickup
- Peter Libby
- Børge G. Nordestgaard
- Giuseppe Jurman
- Davide Chicco
In Epidemiology
- P. Ridker
- B. K. Pedersen
- N. Rifai
- A. M. Petersen
- J. Pickup
- C. Fischer
- M. B. Pepys
- Christie M. Ballantyne
In Surgery
Citations in the corpus
- Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. (2003, background): “The two studies reporting the largest association with high CRP levels were the Women’s Health Study (3) and the West of Scotland Coronary Prevention Study (8), both of which were predominantly composed of white subjects (91% and close to 100%, respectively).”
- Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. (2004, background): “Insulin Resistance and Atherosclerosis Study (CRP, fibrinogen, and PAI-1) (8), in Scottish men in the West of Scotland Coronary Prevention Study (CRP) (9), in the U.”
- Brain-derived neurotrophic factor (BDNF) and type 2 diabetes (2007, background): “Systemic low-grade inflammation is defined as two to fourfold increases in circulating levels of inflammatory markers such as CRP [31], and many reports confirm an association between low-grade systemic inflammation on the one hand, and the metabolic syndrome, type 2 diabetes and atherosclerosis on ”
- The anti-inflammatory effect of exercise. (2005, background): “Low-grade chronic inflammation is reflected by increased C-reactive protein (CRP) concentrations and increased systemic levels of some cytokines (118) and several reports investigating various markers of inflammation in different population groups have confirmed an association between low-grade syst”
- Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005, background): “These effects are not surprising because high-sensitivity CRP levels also predict the onset of type 2 diabetes and adipocytes are a proinflammatory tissue.(28,29)”
- Minireview: adiposity, inflammation, and atherogenesis. (2003, background): “Statins decrease hsCRP by 30–40%, which is not correlated with their cholesterol-lowering capability (103); they consistently improve endothelial function, decrease cardiovascular events and mortality, and in the West of Scotland study decreased new onset type 2 diabetes (104, 105).”
- C-reactive protein: a critical update. (2003, background): “Indeed, CRP production predicts the development of type 2 diabetes independently of traditional risk factors (37).”